Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Oxytocin Add on Study for Stable Schizophrenic Patients (Oxytocin)

This study has suspended participant recruitment.
(Break in funding)
Sponsor:
Collaborator:
Stanley Medical Research Institute
Information provided by (Responsible Party):
David Feifel, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT00506909
First received: July 23, 2007
Last updated: December 11, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):